We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Biomaterial-Based Vaccine That Sits Under the Skin Shows Promise Against SARS-CoV-2

Industry Insight   Aug 17, 2020

Biomaterial-Based Vaccine That Sits Under the Skin Shows Promise Against SARS-CoV-2

OMNIVAX-COVID spike protein: To create vaccine formulations against the SARS-CoV-2 virus, the team included combinations of different antigens derived from the virus’ Spike protein complex in the modular vaccine. Credit: Wyss Institute at Harvard University.

 
 
Advertisement
 
 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE